Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.337 | 0.933 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0136 | 0.359 | 0.359 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.0885 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.337 | 0.933 |
Brugia malayi | MH1 domain containing protein | 0.0024 | 0.0316 | 0.0316 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0885 | 0.1862 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0885 | 0.5 |
Brugia malayi | N-terminal motif family protein | 0.0177 | 0.4802 | 0.4802 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.7765 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0885 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0885 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.0885 | 0.0885 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0063 | 0.1451 | 0.1451 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.0885 | 1 |
Brugia malayi | RNA binding protein | 0.0128 | 0.337 | 0.337 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0128 | 0.337 | 0.337 |
Brugia malayi | Smad1 | 0.0024 | 0.0316 | 0.0316 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.1451 | 0.3467 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0198 | 0.5432 | 0.5432 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0128 | 0.337 | 0.337 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.359 | 0.359 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.0885 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0063 | 0.1451 | 0.3715 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0885 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.1451 | 0.3467 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0024 | 0.0316 | 0.0316 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.0885 | 1 |
Loa Loa (eye worm) | Smad1 | 0.0024 | 0.0316 | 0.0316 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0885 | 0.0885 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0885 | 0.1738 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.337 | 0.933 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0885 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.0885 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.1451 | 0.1451 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0334 | 0.0334 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.337 | 0.933 |
Echinococcus multilocularis | GPCR, family 2 | 0.0063 | 0.1451 | 0.3715 |
Schistosoma mansoni | hypothetical protein | 0.0136 | 0.359 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0128 | 0.337 | 1 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.0885 | 0.0885 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0198 | 0.5432 | 0.5432 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0885 | 0.0885 |
Loa Loa (eye worm) | RNA binding protein | 0.0128 | 0.337 | 0.337 |
Loa Loa (eye worm) | TAR-binding protein | 0.0128 | 0.337 | 0.337 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.0885 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.0885 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0885 | 0.0885 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0885 | 0.0885 |
Brugia malayi | MH2 domain containing protein | 0.0024 | 0.0316 | 0.0316 |
Loa Loa (eye worm) | hypothetical protein | 0.0198 | 0.5432 | 0.5432 |
Echinococcus granulosus | tar DNA binding protein | 0.0128 | 0.337 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0885 | 0.1738 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0354 | 1 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0063 | 0.1451 | 0.3715 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0334 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.0885 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.1451 | 0.3467 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0063 | 0.1451 | 0.1451 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0885 | 0.0885 |
Schistosoma mansoni | tar DNA-binding protein | 0.0128 | 0.337 | 0.933 |
Brugia malayi | beta-lactamase | 0.0043 | 0.0885 | 0.0885 |
Brugia malayi | MH2 domain containing protein | 0.0024 | 0.0316 | 0.0316 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0354 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0334 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0128 | 0.337 | 0.337 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0063 | 0.1451 | 0.3715 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.1451 | 0.3467 |
Brugia malayi | MH1 domain containing protein | 0.0024 | 0.0316 | 0.0316 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.0885 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.0885 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0063 | 0.1451 | 0.3715 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.4802 | 0.4802 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0885 | 0.1862 |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0.0885 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.0885 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0885 | 0.0885 |
Echinococcus granulosus | GPCR family 2 | 0.0063 | 0.1451 | 0.3715 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0885 | 0.0885 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.0885 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0885 | 0.0885 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.0885 | 0.5 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0077 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0334 | 0.0334 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0024 | 0.0316 | 0.0316 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0063 | 0.1451 | 0.1451 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0177 | 0.4802 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0885 | 0.0885 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0198 | 0.5432 | 0.5432 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.31 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.